Assertio Therapeutics, Inc. (ASRT) News
Filter ASRT News Items
ASRT News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ASRT News Highlights
- ASRT's 30 day story count now stands at 2.
- Over the past 8 days, the trend for ASRT's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- PAY and SAM are the most mentioned tickers in articles about ASRT.
Latest ASRT News From Around the Web
Below are the latest news stories about ASSERTIO HOLDINGS INC that investors may wish to consider to help them evaluate ASRT as an investment opportunity.
Is the Options Market Predicting a Spike in Assertio (ASRT) Stock?Investors need to pay close attention to Assertio (ASRT) stock based on the movements in the options market lately. |
Insider Sell: SVP, General Counsel Sam Schlessinger Sells 45,236 Shares of Assertio Holdings IncOn September 11, 2023, Sam Schlessinger, the Senior Vice President and General Counsel of Assertio Holdings Inc (NASDAQ:ASRT), sold 45,236 shares of the company. |
12 Best High Risk Penny Stocks to Buy NowIn this article, we will take a look at the 12 best high risk penny stocks to buy now. To see more such companies, go directly to 5 Best High Risk Penny Stocks to Buy Now. Investors are jubilant over Nvidia crushing analyst estimates in its latest quarterly report. Analysts are increasing their price targets […] |
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)LAKE FOREST, Ill., Aug. 25, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company offering differentiated products to patients, announced that effective August 21, 2023, the Compensation Committee of the Company’s Board of Directors granted one newly-hired employee a total of 11,585 restricted stock units (“RSUs”) and 12,745 stock options (“options”). The RSUs and options were granted as inducements material to each such |
Stonegate Capital Partners Announces Publishing of a Thematic Report - Undervalued Growth Pharma Companies Amidst Healthcare Sector DeclineDallas, Texas--(Newsfile Corp. - August 8, 2023) - Stonegate is pleased to announce the release of a thematic report that examines small market cap pharmaceutical companies based on revenue growth and valuation. The report: Undervalued Growth Pharma Companies Amidst Healthcare Sector Decline examines that represents the top 0.1 percentile of small pharmaceutical growth companies. ... |
Industry Analysts Just Upgraded Their Assertio Holdings, Inc. (NASDAQ:ASRT) Revenue Forecasts By 13%Celebrations may be in order for Assertio Holdings, Inc. ( NASDAQ:ASRT ) shareholders, with the analysts delivering a... |
10 Oversold Value Stocks To BuyIn this piece, we will take a look at ten oversold value stocks to buy. If you want to skip an introduction to value investing and oversold stocks, then take a look at 5 Oversold Value Stocks To Buy. Value investing has multiple benefits, particularly for patient investors. Understanding the complexities of a firm’s business […] |
Why Is Assertio (ASRT) Stock Down 46% Today?Assertio (ASRT) stock is falling hard on Friday after the pharmaceutical company released a mixed earnings report for Q2 2023! |
Why Is DigitalOcean (DOCN) Stock Down 20% Today?DigitalOcean (DOCN) stock isn't doing so hot on Friday following the release of its earnings report for the second quarter of 2023. |
NKLA Stock Alert: What to Know as Nikola CEO Steps DownNikola (NKLA) stock is making waves on Friday after the company announced that CEO Michael Lohscheller is stepping down. |